With the risk of whooping cough infections rising, it's a good time to make sure you're up to date on your Tdap booster, experts say. Whooping cough (pertussis) is a highly infectious respiratory ...
Merck's Adult Vaccine Portfolio Now Includes 9 of the 10 Vaccines on the U.S. CDC's Recommended Adult Immunization Schedule BOSTON & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- MassBiologics (MBL) of ...
ATLANTA -- In certain cases where the tetanus and diphtheria (Td) vaccine is recommended, clinicians may substitute the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, the CDC's Advisory ...
Please provide your email address to receive an email when new articles are posted on . Besides the numerous vaccine products, the possibility of confusing many drug products is even greater, as the ...
In an effort to prevent a shortage, the U.S. Centers for Disease Control and Prevention is advising doctors to conserve the tetanus vaccine because one manufacturer is stopping production. The vaccine ...
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, in a unanimous 14-0 vote, recommended either tetanus, diphtheria, and acellular pertussis ...
Add Yahoo as a preferred source to see more of our stories on Google. The Centers for Disease Control and Prevention is urging doctors to conserve shots of a kind of tetanus vaccine, as the agency ...
The CDC is anticipating a shortage of Td vaccines — which protect against tetanus and diphtheria — as the maker of one shot has discontinued production. As a result, the CDC has updated guidance for ...
Elderly people who received a tetanus-diphtheria-acellular pertussis vaccine (TDaP) were no more likely to suffer adverse reactions than others who received a tetanus and diphtheria vaccine (Td), ...
Add Yahoo as a preferred source to see more of our stories on Google. With the risk of whooping cough infections rising, it's a good time to make sure you're up to date on your Tdap booster, experts ...
BOSTON & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MassBiologics (MBL) of the University of Massachusetts Medical School and Merck & Co., Inc. (NYSE: MRK) announced today that they have entered into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results